SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
397.50    0.00 (0.00%)
Bid:
385.00
Ask:
410.00
Spread: 25.00 (6.494%)
Market Cap: £427.26m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Trading Statement

30 Nov 2009 07:00

RNS Number : 2458D
Origin Enterprises Plc
30 November 2009
 



Trading Update

30 November 2009

 

This Trading Update relates to the three month period ended 31 October 2009.

Origin Enterprises plc ('Origin' or the 'Group') reports a performance in line with our expectations for the first quarter of the 2010 financial year. Reflecting the increased seasonality of the business approximately 20% of annual operating profits are typically earned in the first half of the financial year.

Highlights

Group revenue of €323.5 million, a decrease of 23.8%

Acquisitions completed in the second half of 2009 accounted for 3.3%

The transfer of our Marine Proteins business to Welcon accounted for (3.6%)

Currency accounted for (6.3%)

Reduction in underlying revenues of 17.2% principally due to the impact of lower commodity prices

EBITA* of €12.7 million for the first quarter compared with €21.2 million in the corresponding period last year 

* including share of profit after tax from associates and joint venture

Agri-Nutrition

The Agri-Nutrition division achieved revenues of €252.9m compared with €340.8m in the corresponding period last yearan underlying reduction of 17.5%. This reflects the impact of lower commodity prices and customers adopting a cautious approach to volume commitments in advance of the main application period. The Group's integrated agronomy services business, operating under Masstock in the United Kingdom and Dalgety in Poland, continues to perform well with forecasts for total arable plantings providing a positive platform for the full year performance from this business. 

Food

The Food division generated revenues of €70.6m compared with €83.9m in the corresponding period last year principally reflecting lower agency distribution activityFood has delivered a satisfactory performance against the background of continued weakness in consumer sentiment. Origin's consumer brands continue to demonstrate resilience and are well positioned in categories of consumer spending that are increasingly focused on staple food purchases. 

Joint Venture

The performance of Welcon, Europe's leading manufacturer of marine proteins and oils, is in line with expectations with satisfactory landings of raw material achieved in the period.

Outlook

Customers are adopting a wait and see approach in response to the current challenging environment for farming. The recent uplift in primary output markets, while welcome, has yet to positively impact farm incomes. Against this background we continue to maintain a cautious approach but remain comfortable with market expectations for the full year.

ENDS

Enquiries 

Brendan Fitzgerald

Chief Financial Officer

Origin Enterprises plc151 Thomas Street

Dublin 8

Murray Consultants 

Joe Murray 086 2534950

Pauline Dooley 01 4980300

Tel: +353 1 6121259

Fax: +353 1 6121333

About Origin Enterprises plc

Origin Enterprises plc is a leading Agri-Nutrition and Food company listed on the IEX and AIM markets of the Irish and London Stock Exchanges. The Agri-Nutrition division, through its manufacturing and distribution operations in Ireland, the United KingdomPoland and Norway, has leading market positions in the supply of feed ingredients, integrated agronomy services, crop nutrition and marine proteins and oils. The Group's Food division, comprising sales, marketing, distribution and manufacturing activities in Ireland, has leadership positions in ambient food across the retail, food service and manufacturing sectors.

IEX ticker symbol: OIZ

AIM ticker symbol: OGN

Website: www.originenterprises.com

All comments are based on unaudited management accounts. Certain statements made in this Trading Update are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results referred to in these forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVDLFLKFBLFBD
Date   Source Headline
26th Nov 20245:02 pmRNSHolding(s) in Company
22nd Nov 20247:00 amRNSBoard Committee Membership Update
21st Nov 20244:22 pmRNSAGM
21st Nov 20247:00 amRNSQ1 Trading Update
6th Nov 20247:00 amRNSAppointment of Non-Executive Director
4th Nov 20243:24 pmRNSHolding(s) in Company
4th Nov 20247:00 amRNSBlock Listing Six Monthly Return
31st Oct 202411:30 amRNSFurther expansion of Environmental business
25th Oct 20243:18 pmRNSPosting of 2024 Annual Report and Notice of AGM
24th Oct 20242:00 pmRNS2024 Annual Report and Sustainability Report
17th Oct 20245:50 pmRNSDirector/PDMR Shareholding
17th Oct 20244:16 pmRNSHolding(s) in Company
16th Oct 20243:11 pmRNSDirector/PDMR Shareholding
14th Oct 20245:55 pmRNSDirectorate Change
26th Sep 202412:00 pmRNSDirector/PDMR Shareholding
26th Sep 202412:00 pmRNSDirector/PDMR Shareholding
26th Sep 202412:00 pmRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSDirectorate Change
24th Sep 20247:00 amRNSFinal Results
16th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20244:53 pmRNSHolding(s) in Company
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 202411:30 amRNSAcquisition of two specialist ecology businesses
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.